PECAM1 and neoplasm: According to the flow cytometry analysis of tumor tissue, a significant increase in CD31 + VCAM-1 + cells was observed in the TU2218-administered group, and a significant increase in CD8 + T cells was observed in the anti-PD1 and TU2218-administered group (Fig. 6c).